Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
2.510
+0.130 (5.46%)
Nov 21, 2024, 12:11 PM EST - Market open

Phio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
22514166
Upgrade
Market Cap Growth
-11.49%-63.48%-62.43%-12.96%146.99%5.09%
Upgrade
Enterprise Value
-3-6-9-13-1-2
Upgrade
Last Close Price
2.386.8440.18108.00290.521015.74
Upgrade
Forward PE
0.110.210.372.19--
Upgrade
PS Ratio
-----299.79
Upgrade
PB Ratio
0.480.240.470.621.191.10
Upgrade
P/TBV Ratio
0.600.240.470.621.191.10
Upgrade
Debt / Equity Ratio
-0.000.020.010.050.09
Upgrade
Asset Turnover
-----0.00
Upgrade
Quick Ratio
5.875.206.087.846.493.69
Upgrade
Current Ratio
6.385.716.428.066.913.88
Upgrade
Return on Equity (ROE)
-122.03%-116.60%-70.06%-76.04%-93.73%-92.19%
Upgrade
Return on Assets (ROA)
-60.11%-59.86%-37.72%-41.28%-46.22%-48.09%
Upgrade
Return on Capital (ROIC)
-75.72%-70.71%-43.11%-47.06%-55.16%-56.61%
Upgrade
Earnings Yield
-357.66%-582.98%-225.79%-98.17%-56.55%-141.50%
Upgrade
FCF Yield
-391.02%-579.10%-240.93%-87.99%-56.73%-138.46%
Upgrade
Buyback Yield / Dilution
-227.50%-83.32%-6.30%-179.70%--
Upgrade
Total Shareholder Return
-227.50%-83.32%-6.30%-179.70%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.